{"id":94180,"date":"2025-09-10T19:00:36","date_gmt":"2025-09-11T00:00:36","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/felicitaties-voor-laura-eurelings-md-phd\/"},"modified":"2025-09-10T19:01:28","modified_gmt":"2025-09-11T00:01:28","slug":"felicitaties-voor-laura-eurelings-md-phd","status":"publish","type":"post","link":"https:\/\/www.erdheim-chester.org\/nl\/felicitaties-voor-laura-eurelings-md-phd\/","title":{"rendered":"Felicitaties voor Laura Eurelings, MD, PhD!"},"content":{"rendered":"<p>Tijdens het <strong>2025 Erdhem-Chester Disease Medical Symposium in Barcelona<\/strong> ging de <strong>ECDGA Junior Investigator Award<\/strong> naar <strong>Laura Eurelings<\/strong> van het Erasmus Universitair Medisch Centrum, Rotterdam.<\/p>\n<p>Haar poster, <em>&#8220;Anti-IL-6 Therapy in Rare Histiocytic Disorders: Erdheim-Chester and Rosai-Dorfman Disease&#8221;<\/em> toonde aan dat <strong>tocilizumab mogelijk een effectieve optie is voor pati\u00ebnten<\/strong>, vooral voor pati\u00ebnten die mutatienegatief zijn of niet in aanmerking komen voor BRAF-remmers.<\/p>\n<p>De betrokkenheid van beginnende onderzoekers bij onderzoek zorgt voor frisse idee\u00ebn en nieuwe energie en helpt de wetenschap over zeldzame ziekten vooruit. Laura&#8217;s werk is een perfect voorbeeld van hoe jonge onderzoekers echte impact hebben en de kennis over ECD verbeteren! <\/p>\n<p>Vier samen met ons Laura&#8217;s prestatie en haar bijdrage aan de ECD gemeenschap.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tijdens het 2025 Erdhem-Chester Disease Medical Symposium in Barcelona ging de ECDGA Junior Investigator Award naar Laura Eurelings van het Erasmus Universitair Medisch Centrum, Rotterdam. Haar poster, &#8220;Anti-IL-6 Therapy in [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":94199,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_wds_title":"","_wds_metadesc":"","_wds_focus-keywords":"","_wds_meta-robots-adv":"","_wds_meta-robots-noindex":false,"_wds_meta-robots-nofollow":false,"_wds_meta-robots-index":false,"_wds_meta-robots-follow":false,"_wds_autolinks-exclude":false,"_wds_canonical":"","_wds_redirect":"","_wds_opengraph":[],"_wds_twitter":[],"cybocfi_hide_featured_image":"","wds_primary_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[420],"tags":[3218,500,473,2475,4661,4290],"class_list":["post-94180","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ecdga-nieuws","tag-ecd-nl","tag-ecdga-nl","tag-erdheimchesterdisease-nl","tag-medischsymposium","tag-toekomst-van-het-onderzoek","tag-zeldzameziektenonderzoek"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/nl\/wp-json\/wp\/v2\/posts\/94180","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/nl\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/nl\/wp-json\/wp\/v2\/comments?post=94180"}],"version-history":[{"count":0,"href":"https:\/\/www.erdheim-chester.org\/nl\/wp-json\/wp\/v2\/posts\/94180\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/nl\/wp-json\/wp\/v2\/media\/94199"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/nl\/wp-json\/wp\/v2\/media?parent=94180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/nl\/wp-json\/wp\/v2\/categories?post=94180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/nl\/wp-json\/wp\/v2\/tags?post=94180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}